Gene Green: “I would like this bill to do what we did for the pharmaceutical industry, because, believe me, I want not only…”

The Cures Act aimed to build on the progress of the HITECH Act of 2009, but by focusing on improving interoperability, patient access to their health records, and reducing provider burden.

Critically, MACRA encourages providers to move away from fee-for-service and participate in a new delivery model that will reduce costs while increasing quality.

I hope we all agree on the importance of 340B and the need to stretch scarce federal resources as far as possible to reach more eligible patients and provide more comprehensive services.

I am extremely disappointed that 2 years after the passage of Cures we still do not have the regulations necessary to implement these provisions.